2020•Journal of NeuroimmunologyOpen access

Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS)

Marcus Vinícius Magno Gonçalves, Wesley Nogueira Brandão, Carla Longo, Jean Pierre Schatzmann Peron, Giordani Rodrigues dos Passos, Gabriela Löw Pagliarini, Osvaldo J. M. Nascimento, Daniel Rodrigo Marinowic, Denise Cantarelli Machado, Jéfferson Becker

Open full text 3 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Fingolimod, Multiple sclerosis, Glatiramer acetate, Medicine, Relapsing remitting, Internal medicine, Randomized controlled trial, McDonald criteria